In summary, the present findings suggest that expression of the hepatic htr2b is increased in young diabetic db/db mice and KKAy mice, and pharmacologic inhibition of htr2b ameliorates the hyperglycemia and altered expression of hepatic FGF21, Sdf2l1 and htr2a in these mice. The gene discussed is SDF2L1; the disease is Hyperglycemia.